ABSTRACT
Introduction
Gliomas account for more than 50% of primary malignant tumors of the central nervous system with high mortality rates and high incidence rates 1 . World Health Organization (WHO) classifies gliomas to four grades (I-IV) with increasing degree of malignancy 2 . Grade IV, glioma-glioblastoma multiforme (GBM) is the most aggressive type of primary brain tumors with the median survival time of patients less than 14 months even with multimodal therapy comprising the combination of surgery, radiation therapy and chemotherapy 3, 4 . The major reason is that the diffuse invasion of tumor cells invading the surrounding brain shelters themselves from surgery and radiation. The malignant glioma seems to proliferate indefinitely. Consequently, development of novel biologicals in brain tumor therapy is crucial.
Recently, the use of phytochemicals as anti-cancer agent has gained high importance. Many plant-derived compounds as cucurmin 5 , gingerol 6 and silibinin 7 , have been reported to restrain tumor growth in a series of experiments. Ellagic acid (EA) is a natural phenol present in many fruits and vegetables as cranberries, strawberries, blackberries, raspberries, grapes, and walnuts et al. 8 . As a dimeric form of gallic acid, it comprises of a fused four-ring structure with four hydroxyl groups and two lactone rings representing the hydrophilic part ( Figure 1 ). EA has been found to possess various pharmacological properties as anticarcinogenic, antioxidant, antifibrosis, and chemopreventive properties [9] [10] [11] . Numerous scientific reports have evaluated the anticancer property of EA both in vivo and in vitro models for various kinds of cancer such as thyroid, breast, prostate, urinary bladder and blood cancer [12] [13] [14] [15] . In spite of these findings, the inhibition of glioblastoma growth by EA has been rarely reported.
Here in the present study we investigated the influence of EA on the proliferation and apoptosis of human glioblastoma cells and its possible mechanism. 
Methods

Cell lines and culture
Live/dead assay
The cells were exposed to EA (0, 50 and 100µM) for 48 h. The LIVE/DEAD cell viability assay (Invitrogen) determines the intracellular esterase activity and cell membrane integrity, to assess cell viability. Live cells retain calcein-AM and produce a green fluorescence through esterase activity, while, the ethidium homodimer binds to nucleic acid of the dead cells and produce red fluorescence. Glioblastoma cells, treated with EA were stained with calcein-AM (5µmol/L) and ethidium homodimer (5µmol/L) and were incubated at 37°C for 30 minutes and analyzed using a Nikon labophot-2 fluorescence microscope.
Mitochondrial membrane potential assay
The influence of EA on mitochondrial membrane potential (MMP) was detected with JC-1 Mitochondrial Membrane Potential Assay Kit (Cayman Chemical, USA). Culturing cells in 6-well plates at a density of 5x10 
Cell apoptosis and cell cycle distribution analysis
The influence of EA on apoptosis and cell cycle distribution were detected with the Annexin V-FITC/PI apoptosis kit and cell cycle kit separately according to the manufacturer's instructions from MultiSciences Biotech (Hangzhou, China). U251 cells were exposed to EA for 48h. At the end of the treatment period, about 1x10 6 cells were trypsinized, collected by centrifugation at 900 rpm for 5 minutes and washed with cold PBS. Then corresponding regents and solution were added and incubated according to manufacturer's instructions respectively. At the end of incubation, cell apoptosis and cell cycle distribution were analyzed on a flow cytometer (BD Biosciences, USA).
Western blot analysis
Cell proteins were extracted with RIPA lysis buffer and determined by the standard BCA method (Beyotime Institute of Biotechnology, Shanghai, China). Equal amounts of protein (40µg) were separated by SDS-PAGE and electroblotted onto polyvinylidene difluoride membranes (Millipore Corp., Bedford, MA, USA). Membranes were blocked in TBS containing 0.1% Tween-20 and 5% powdered milk, and probed with primary antibody. Primary antibody directed against Bcl-2, Survivin, XIAP, caspase-3, Bax, JNK, P-JNK, ERK1/2, P-ERK1/2, p38, p-p38, DR4, DR5, CHOP, GRP78, GAPDH and β-actin were used at a dilution according to their specifications. Blots were visualized by LI-COR Odyssey Infrared imaging System with Alex Fluor 680/790 labeled goat anti-rabbit and goat anti-mouse IgG (LI-COR Biosciences, USA) used as second antibody.
Statistical analysis
All experimental results are represented as mean±SD. The Student's t-test was used to determine the significances between two mean values, and more than two values are determined by one-way Analysis of variance (ANOVA). Values at p<0.05 were considered statistically significant. The obtained values were analyzed using SPSS software, version 21.0.
Results
EA suppressed the cell viability of glioblastoma cells
In order to investigate whether EA treatment affects cell viability, U251 cells treated with various concentrations (0-200µM) of EA were tested using CCK-8 at several different time points. EA significantly reduced cell viability in U251 cells in a time and dose-dependent manner. And EA at 100 µM was more effective on U251 MG than 50 µM. Exposure to 100 µM EA reduced the cell viability of U251 MG to 33.24% (Figure 2 ). FIGURE 2 -EA suppresses the cell viability of glioblastoma cells. U251 cells were exposed to culture medium containing various concentrations of EA for different time periods, and then cell viability was measured using the CCK-8 assay. The data were represented by mean±SD of three experiments, and each experiment was conducted in triplicate.
Live/dead assay
Live/Dead assay for determination of cell viability was performed to assess if EA had cytotoxicity effects. Exposure to 50 µM EA resulted in a marked increase (p<0.05) in the apoptotic cell counts, the cytotoxicity percentage rose to 27.21 % in U251 MG. As exposure to 100 µM EA, interestingly, caused robust increase in cytotoxicity to 53.79 % in U251 MG (p<0.05) (Figure 3) . 
Mitochondrial membrane potential assay
Mitochondrial Membrane Potential Assay Kit provides the most robust assay method for monitoring MMP changes. In normal cells, JC-1 concentrates in the mitochondrial matrix where it forms red fluorescent aggregates. And, in apoptotic and necrotic cells, JC-1 diffuses out of mitochondria. It changes to monomeric form and stains cells in green fluorescence. We observed that EA exposure increased the green fluorescence rate of U251 cells to 16.83% and 50.59% separately with a dose of 50µM and 100µM EA than that of the control group (p<0.05) (Figure 4 ). It indicates that with the increasing of EA concentrations, the number of cells with MMP decrease is increasing. 
EA induced cell apoptosis of glioblastoma cells
The effect of EA on cell apoptosis was investigated by flow cytometry. The apoptosis rates at 48 h after treatment with and without EA are shown in Figure 5 (A, B, and C). EA exposure increased the apoptosis rate of U251 cells to 11.3% and 34.5% separately with a dose of 50µM and 100µM ( Figure 5D ). The results indicated that EA induced apoptosis in glioblastoma U251 MG. 
EA affected the cell cycle progression of glioblastoma cells
In order to examine the possible mechanism of antiproliferation and pro-apoptosis activity of EA, the cell cycle distribution of U251 MG was evaluated by flow cytometry in presence and absence of EA. As shown in Figure 6 , cultivating 
EA affected cell apoptotic and survival signaling in glioblastoma cells.
Changes in the expression of proteins related to cell apoptotic and survival signaling were analyzed by western blot in order to determine the mechanism of EA-induced inhibitory effects. We studied the effects of EA on the activation of Caspases. EA at 50 and 100 µM significantly (p<0.05) up-regulated the expression levels of Caspase-3 in a dose-dependent manner in the U251 glioma cell lines. Further, EA significantly (p<0.05) inhibited the expressions of Bcl-2, Survivin and XIAP, whereas up-regulated the pro-apoptotic protein, Bax (Figure 7 ). We investigated whether the activation of MAP kinases-ERK1/2, p38 and JNK exert their roles in EA-induced apoptosis. Incubation with EA caused significant (p<0.05) up-regulations in the expression patterns of ERK1/2, JNK and p38. EA caused multifold elevations in the phosphorylated forms of ERK1/2 and JNK, resulting in activation of ERK1/2 and JNK. Though considerable increase in p-p38 levels were observed, the elevations were non-significant. Further, EA caused marked up-regulation of p-ERK1/2 than p-JNK levels, suggesting that ERK is more involved in this signal pathway (Figure 8 ). To investigate the influence of EA on the expressions of DR5 and CHOP at the protein level, western blot was performed. EA also induced the expressions of DR5, DR4 and CHOP at the protein levels also as observed in western blot analysis ( Figure  9 ). However, the up-regulation of DR5 and CHOP were more pronounced than DR4. Furthermore, the ER stress marker proteins as-GRP78 induces the expression of CHOP. EA caused marked increase in the expression of GRP78 that could have possibly induced the expression of CHOP, indicating the involvement of ER stress in EA-induced apoptosis ( Figure 9 ). 
Discussion
In spite of continuous efforts to improve the current conventional cancer treatments, the long-term outcomes following surgery, chemotherapy and/or radiotherapy are still not optimal. Further, the lack of selectivity of these approaches towards cancer cells leads to significant side-effects and toxicity. Glioblastoma multiforme (GBM) is a highly aggressive major primary brain tumor in adults 16 and is a challenge to treat GBM 17 . Thus it becomes vital to identify novel agents that can inhibit its proliferation.
EA, a naturally occurring dietary polyphenolic compound, is present in several plants and fruits. EA is a dimeric derivative of gallic acid, which occurs in fruits and nuts either in the free form, as EA-glycosides, or as bound ETs 18 . EA has antioxidant, antifibrotic, and anticarcinogenic properties et al. 19 . It has been shown to reduce the incidence of a variety of carcinogen-induced tumors 20 . The anticarcinogenic effect of EA was shown in several types of cancers [21] [22] [23] [24] [25] . In our study we observed, EA at 25-200µM strikingly reduced the cell viability of U251 cells, suggesting the anti-proliferative efficacy. EA significantly down-regulated the expressions of anti-apoptotic proteins, Bcl-2 and Survivin. Apart from that, it enhanced the expressions of Caspase-3 and proapoptotic protein, Bax as well. The modulations in the expression patterns observed was dose-dependent, with 200 µM EA had a maximum influence on expressions.
Also, over expression of other anti-apoptotic proteins, including cellular FLICE-like inhibitory protein (c-FLIP) 26 , and inhibitor of apoptosis proteins (IAPs) as XIAP were also reported in cells inducing apoptosis. We also found EA induced downregulation of XIAP also could have contributed to the activation of the Caspase cascade leading to apoptosis.
It has been shown that the induction of DR5 is also mediated through activation of CHOP 27 . CHOP is a major endoplasmic reticulum (ER) stress-regulated protein that is involved in ER stress-induced apoptosis 28 . EA enhanced the expression of CHOP at the protein level in a dose-dependent way. CHOP expression is principally regulated at the transcriptional level and is also one of the most induced genes during ER stress 29 .
Additionally, CHOP expression is enhanced during conditions of stress as when cells were deprived of essential nutrients, and on exposure to anticancer drugs 30, 31 . The results of our study suggest that EA possibly induced ER stress that leads to induction of GRP78 and CHOP expressions.
Recent research works have suggested that MAPKs-p38 MAPK and ERK1/2, regulate the expression of DR4 and DR5 32, 33 . Also, stress activated protein, JNK regulates mitochondrial apoptotic pathway 34 . EA induced activation and elevated expressions of JNK, ERK1/2 and p38 suggest the involvement of the MAPK signalling cascades in EA-induced apoptosis. Our results indicate that EA could have contributed to stress and further caused activation of JNK, suggesting the involvement of ROS-JNK/ERK signalling in cell death. Collectively the results of our study suggest that EA potentiates glioblastoma cells apoptosis by up-regulating the death receptors and through the activation of CHOP. EA could be possibly employed in chemotherapy for gliomas.
Conclusions
We demonstrated that EA inhibited the proliferation and induced apoptosis of human glioblastoma cell lines. The cell apoptosis and cell cycle arrest caused by EA could be involved in mechanism of anticancer effects of EA on these human brain malignant tumor cells. However, epigenetic alternations and in-vivo experiments were absent in this research. In addition, the evidences of EA negatively regulating the invasiveness and growth of glioblastoma cells in vitro experiments will provide more convincing basis to support that EA may be a candidate to treat malignant brain tumors in the future.
